Abo Elnaga, N. I. E., Massoud, M. I., Yousef, M. I., & Mohamed, H. H. A. (2016). Effect of stevia sweetener consumption as non-caloric sweetening on body weight gain and biochemical’s parameters in overweight female rats. Annals of Agricultural Sciences, 61(1), 155–163.

Abou Zaid, O., Elsonbaty, S., Moawad, F., & Abdelghaffar, M. (2019). Antioxidants and hepatoprotective effects of chitosan nanoparticles against hepatotoxicity induced in rats. Benha Veterinary Medical Journal, 36(1), 252–261.

Ahmad, U., Ahmad, R. S., Shahbaz, M., Imran, A., Haseeb, M., Siddique, F., Yasmin, Z., Ashraf, I., Masroor, A., & Basit, A. (2020). Hematological and toxicological effects of aqueous leaf extract of Stevia rebaudiana Bertoni in normal rat modals. Pakistan Journal of Pharmaceutical Sciences, 33(5S), 2249–2255.

Alqahtani, L. S., Abd-Elhakim, Y. M., Mohamed, A. A.-R., Khalifa, N. E., Khamis, T., Alotaibi, B. S., Alosaimi, M., El-Kholy, S. S., Abuzahrah, S. S., El Ashmouny, N., Eskandrani, A. A., & Gaber, R. A. (2023). Curcumin-loaded chitosan nanoparticles alleviate fenpropathrin-induced hepatotoxicity by regulating lipogenesis and pyroptosis in rats. Food and Chemical Toxicology, 180, 114036.

Badwan, A., Rashid, I., Omari, M., & Darras, F. (2015). Chitin and chitosan as direct compression excipients in pharmaceutical applications. Marine Drugs, 13(3), 1519–1547.

Bensinger, S. J., & Tontonoz, P. (2008). Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature, 454(7203), 470–477.

Brijesh, K., & Kamath, M. (2016). Experimental evaluation of anti-hyperglycemic and hypolipidemic effects of Stevia rebaudiana, Anacardium occidentale on wistar rats. International Journal of Basic and Clinical Pharmacology, 5(6), 2463–2467.

Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A. (2021). The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism, 114, 154338.

Coll, T., Rodriguez-Calvo, R., Barroso, E., Serrano, L., Eyre, E., Palomer, X., & Vazquez-Carrera, M. (2009). Peroxisome proliferator-activated receptor (PPAR) β/δ: A new potential therapeutic target for the treatment of metabolic syndrome. Current Molecular Pharmacology, 2(1), 46–55.

Curry, L. L., & Roberts, A. (2008). Subchronic toxicity of rebaudioside A. Food and Chemical Toxicology, 46(7), S11–S20.

Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., Sharma, A., Giri, J., Benival, D., & Kommineni, N. (2023). Chitosan: A potential biopolymer in drug delivery and biomedical applications. Pharmaceutics, 15(4), 1313.

Duraisamy, N., Dhayalan, S., Shaik, M. R., Shaik, A. H., Shaik, J. P., & Shaik, B. (2022). Green synthesis of chitosan nanoparticles using of Martynia annua L. ethanol leaf extract and their antibacterial activity. Crystals, 12(11), 1550.

Dyduch-Siemińska, M., Najda, A., Gawroński, J., Balant, S., Świca, K., & Żaba, A. (2020). Stevia rebaudiana Bertoni, a source of high-potency natural sweetener-biochemical and genetic characterization. Molecules, 25(4), 767.

El-Naggar, N. E.-A., Saber, W. I. A., Zweil, A. M., & Bashir, S. I. (2022). An innovative green synthesis approach of chitosan nanoparticles and their inhibitory activity against phytopathogenic Botrytis cinerea on strawberry leaves. Scientific Reports, 12(1), 3515.

Gardana, C., Simonetti, P., Canzi, E., Zanchi, R., & Pietta, P. (2003). Metabolism of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. Journal of Agricultural and Food Chemistry, 51(22), 6618–6622.

Garg, U., Chauhan, S., Nagaich, U., & Jain, N. (2019). Current advances in chitosan nanoparticles based drug delivery and targeting. Advanced Pharmaceutical Bulletin, 9(2), 195–204.

Geuns, J. M. C., Augustijns, P., Mols, R., Buyse, J. G., & Driessen, B. (2003). Metabolism of stevioside in pigs and intestinal absorption characteristics of stevioside, rebaudioside A and steviol. Food and Chemical Toxicology, 41(11), 1599–1607.

Geuns, J. M., Buyse, J., Vankeirsbilck, A., & Temme, E. H. (2007). Metabolism of stevioside by healthy subjects. Experimental Biology and Medicine, 232(1), 164–173.‏

Goyal, S. K., Samsher, & Goyal, R. K. (2009). Stevia (Stevia rebaudiana) a bio-sweetener: A review. International Journal of Food Sciences and Nutrition, 61(1), 1–10.

Gupta, E., Purwar, S., Sundaram, S., & Rai, G. K. (2013). Nutritional and therapeutic values of Stevia rebaudiana: A review. Journal of Medicinal Plants Research, 7, 3343–3353.

Ha, N. M. C., Nguyen, T. H., Wang, S.-L., & Nguyen, A. D. (2018). Preparation of NPK nanofertilizer based on chitosan nanoparticles and its effect on biophysical characteristics and growth of coffee in green house. Research on Chemical Intermediates, 45(1), 51–63.

Hamza, M. F., Wei, Y., Althumayri, K., Fouda, A., & Hamad, N. A. (2022). Synthesis and characterization of functionalized chitosan nanoparticles with pyrimidine derivative for enhancing ion sorption and application for removal of contaminants. Materials, 15(13), 4676.

Heidari, Z., Chrisman, I. M., Nemetchek, M. D., Novick, S. J., Blayo, A.-L., Patton, T., Mendes, D. E., Diaz, P., Kamenecka, T. M., Griffin, P. R., & Hughes, T. S. (2019). Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ. Nature Communications, 10(1), 5825.

Iman, M. M. (2011). Effect of aspartame on some oxidative stress parameters in liver and kidney of rats. African Journal of Pharmacy and Pharmacology, 5(6), 678–862.

Jeon, T. I., Hwang, S. G., Park, N. G., Jung, Y. R., Shin, S. I., Choi, S. D., & Park, D. K. (2003). Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology, 187(1), 67–73.

Koyama, E., Sakai, N., Ohori, Y., Kitazawa, K., Izawa, O., Kakegawa, K., Fujino, A., & Ui, M. (2003). Absorption and metabolism of glycosidic sweeteners of stevia mixture and their aglycone, steviol, in rats and humans. Food and Chemical Toxicology, 41(6), 875–883.

Kurek, J. M., & Krejpcio, Z. (2019). The functional and health-promoting properties of Stevia rebaudiana Bertoni and its glycosides with special focus on the antidiabetic potential – A review. Journal of Functional Foods, 61, 103465.

Lv, Y., Gao, X., Luo, Y., Fan, W., Shen, T., Ding, C., Yao, M., Song, S., & Yan, L. (2019). Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. The Journal of Nutritional Biochemistry, 71, 110–121.

Matsusue, K., Gavrilova, O., Lambert, G., Brewer, H. B., Ward, J. M., Inoue, Y., LeRoith, D., & Gonzalez, F. J. (2004). Hepatic CCAAT/enhancer binding protein α mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Molecular Endocrinology, 18(11), 2751–2764.

Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., Palmer, C. N. A., Plutzky, J., Reddy, J. K., Spiegelman, B. M., Staels, B., & Wahli, W. (2006). International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews, 58(4), 726–741.

Mukhopadhyay, P., Sarkar, K., Chakraborty, M., Bhattacharya, S., Mishra, R., & Kundu, P. P. (2013). Oral insulin delivery by self-assembled chitosan nanoparticles: In vitro and in vivo studies in diabetic animal model. Materials Science and Engineering: C, 33(1), 376–382.

Nakamura, A., & Terauchi, Y. (2013). Lessons from mouse models of high-fat diet-induced NAFLD. International Journal of Molecular Sciences, 14(11), 21240–21257.

Neimert-Andersson, T., Hällgren, A.-C., Andersson, M., Langebäck, J., Zettergren, L., Nilsen-Nygaard, J., Draget, K. I., van Hage, M., Lindberg, A., Gafvelin, G., & Grönlund, H. (2011). Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine. Vaccine, 29(48), 8965–8973.

Nguyen, T. V., Nguyen, T. T. H., Wang, S.-L., Vo, T. P. K., & Nguyen, A. D. (2016). Preparation of chitosan nanoparticles by TPP ionic gelation combined with spray drying, and the antibacterial activity of chitosan nanoparticles and a chitosan nanoparticle – amoxicillin complex. Research on Chemical Intermediates, 43(6), 3527–3537.

Ong, T. H., Chitra, E., Ramamurthy, S., Siddalingam, R. P., Yuen, K. H., Ambu, S. P., & Davamani, F. (2017). Chitosan-propolis nanoparticle formulation demonstrates antibacterial activity against Enterococcus faecalis biofilms. PLoS One, 12(3), e0174888.

Ozdek, U., Toz, H., Kömüroğlu, A., Mis, L., & Değer, Y. (2023). The impact of chitosan on oxidative stress in liver of rats loaded with lead acetate. Journal of the Hellenic Veterinary Medical Society, 73(4), 4703–4708.

Park, M., Sharma, A., Baek, H., Han, J.-Y., Yu, J., & Lee, H.-J. (2022). Stevia and stevioside attenuate liver steatosis through PPARα-mediated lipophagy in db/db mice hepatocytes. Antioxidants, 11(12), 2496.

Pradhan, N., & Dwivedi, P. (2016). In vitro shoot multiplication of Stevia rebaudiana, an important plant with high economic and medicinal values. Vegetos, 29(4), 69–75.

Ramos-Tovar, E., & Muriel, P. (2019). Phytotherapy for the liver. In: Watson, R. R., & Preedy, V. R. (Eds.). Dietary interventions in liver disease. Academic Press, London. Pp. 101–121.

Rojas, E., Bermúdez, V., Motlaghzadeh, Y., Mathew, J., Fidilio, E., Faria, J., Rojas, J., de Bravo, M. C., Contreras, J., Mantilla, L. P., Angarita, L., Sepúlveda, P. A., & Kuzmar, I. (2018). Stevia rebaudiana Bertoni and its effects in human disease: Emphasizing its role in inflammation, atherosclerosis and metabolic syndrome. Current Nutrition Reports, 7(3), 161–170.

Sharma, S., Gupta, S., Kumari, D., Kothari, S. L., Jain, R., & Kachhwaha, S. (2023). Exploring plant tissue culture and steviol glycosides production in Stevia rebaudiana (Bert.) Bertoni: A review. Agriculture, 13(2), 475.

Slimani, C., Sqalli, H., Rais, C., Farah, A., Lazraq, A., Ghadraoui, L. E., Belmalha, S., & Echchgadda, G. (2022). Chemical composition and evaluation of biological effects of essential oil and aqueous extract of Lavandula angustifolia L. Notulae Scientia Biologicae, 14(1), 11172.

Tao, W., Sun, W., Liu, L., Wang, G., Xiao, Z., Pei, X., & Wang, M. (2019). Chitosan oligosaccharide attenuates nonalcoholic fatty liver disease induced by high fat diet through reducing lipid accumulation, inflammation and oxidative stress in C57BL/6 mice. Marine Drugs, 17(11), 645.

Todisco, S., Santarsiero, A., Convertini, P., De Stefano, G., Gilio, M., Iacobazzi, V., & Infantino, V. (2022). PPAR alpha as a metabolic modulator of the liver: Role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Biology, 11(5), 792.

Wang, Z., Yan, Y., Yu, X., Li, W., Li, B., & Qin, C. (2016). Protective effects of chitosan and its water-soluble derivatives against lead-induced oxidative stress in mice. International Journal of Biological Macromolecules, 83, 442–449.

Wheeler, A., Boileau, A. C., Winkler, P. C., Compton, J. C., Prakash, I., Jiang, X., & Mandarino, D. A. (2008). Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Food and Chemical Toxicology, 46(7), S54–S60.

Yanat, M., & Schroën, K. (2021). Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. Reactive and Functional Polymers, 161, 104849.